MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meetin

SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that two posters presenting preclinical data will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 for zandelisib, an...

Related Keywords

United States ,American ,Katie Hurrish ,Davida Walsey ,American Association For Cancer Research ,Linkedin ,Drug Administration ,Canale Communications ,Pharma Inc ,Nasdaq ,American Association ,Cancer Research ,Annual Meeting ,Intermittent Dosing Regimen ,Private Securities Litigation Reform Act ,